FocalTherics 

$4.71
6
-$0.08-1.67% Today

Statistics

Day High
4.8
Day Low
4.65
52W High
5.05
52W Low
1.21
Volume
127,392
Avg. Volume
-
Mkt Cap
176.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

28AugExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.15
-0.1
-0.05
Expected EPS
-0.18
Actual EPS
-0.17

Financials

-29.94%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
137.96MRevenue
-41.31MNet Income

Analyst Ratings

10.00Average Price Target
The highest estimate is 10.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EDAP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap145.58B
Intuitive Surgical is a leading company in the field of robotic-assisted surgery, competing with EDAP TMS in the broader market for medical devices used in minimally invasive procedures.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation offers a wide range of medical devices including those for minimally invasive surgeries, making it a competitor in the medical device market.
Medtronic
MDT
Mkt Cap102.97B
Medtronic plc provides medical technologies, services, and solutions, including surgical products that compete with EDAP TMS's offerings.
Smith & Nephew
SNN
Mkt Cap12.95B
Smith & Nephew specializes in surgical devices, including those for minimally invasive surgery, competing with EDAP TMS in the surgical equipment market.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. is involved in musculoskeletal healthcare, including surgical solutions, competing in the broader medical device market against EDAP TMS.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation is a medical technologies firm with products in various surgical fields, directly competing with EDAP TMS in the medical device sector.
Edwards Lifesciences
EW
Mkt Cap49.01B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing in the medical device market for specialized surgical applications.
Globus Medical
GMED
Mkt Cap10.91B
Globus Medical, Inc. specializes in musculoskeletal solutions, including minimally invasive surgical tools, competing in the broader market for surgical devices.

About

EDAP TMS S.A., a medical technology firm headquartered in Lyon, France, since its inception in 1979, innovates, manufactures, and globally distributes advanced, minimally invasive medical devices. With a primary focus on addressing urological diseases through sophisticated solutions, the company operates across Asia, France, the United States, and other international markets. Its business operations are divided into three distinct segments: 1. High Intensity Focused Ultrasound (HIFU): This segment concentrates on developing and advancing HIFU technology for the minimally invasive treatment of urological and various other clinical indications. Its product portfolio encompasses the Ablatherm, an ultrasound-guided robotic HIFU device for organ-confined prostate cancer; the Ablatherm Fusion, which features proprietary fusion software that merges MRI and ultrasound images for precise targeting; and the Focal One, a robotic HIFU device specifically designed for the focal therapy of prostate cancer. The segment also provides necessary disposables, leasing and treatment-related services, and ongoing maintenance. 2. Extracorporeal ShockWave Lithotripsy (ESWL): This division is responsible for manufacturing and marketing lithotripters utilizing ESWL technology to treat urinary tract stones. Its flagship, the Sonolith i-move, is an extracorporeal shockwave lithotripter well-suited for small to mid-sized hospitals, with accompanying sales of disposable parts and electrodes. 3. Distribution Services (DIST): This segment oversees the marketing, distribution, and servicing of various medical products from third-party manufacturers, such as lasers and micro-ultrasound systems. This segment's offerings also extend to device leasing, the sale of disposables and spare parts, and comprehensive maintenance support. The company serves a broad customer base, including hospitals, urology clinics, and research institutions, leveraging both its direct marketing, sales, and service platform, as well as a network of third-party distributors and agents.
Show more...
CEO
Mr. Ryan Rhodes
Employees
310
Country
France
ISIN
US2683111072

Listings

0 Comments

Share your thoughts

FAQ

What is FocalTherics stock price today?
The current price of EDAP is $4.71 USD — it has decreased by -1.67% in the past 24 hours. Watch FocalTherics stock price performance more closely on the chart.
What is FocalTherics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange FocalTherics stocks are traded under the ticker EDAP.
Is FocalTherics stock price growing?
EDAP stock has risen by +2.84% compared to the previous week, the month change is a +12.95% rise, over the last year FocalTherics has showed a +170.69% increase.
What is FocalTherics market cap?
Today FocalTherics has the market capitalization of 176.34M
What were FocalTherics earnings last quarter?
EDAP earnings for the last quarter are -0.17 USD per share, whereas the estimation was -0.18 USD resulting in a +5.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is FocalTherics revenue for the last year?
FocalTherics revenue for the last year amounts to 137.96M USD.
What is FocalTherics net income for the last year?
EDAP net income for the last year is -41.31M USD.
How many employees does FocalTherics have?
As of June 16, 2026, the company has 310 employees.
In which sector is FocalTherics located?
FocalTherics operates in the Health & Wellness sector.
When did FocalTherics complete a stock split?
FocalTherics has not had any recent stock splits.
Where is FocalTherics headquartered?
FocalTherics is headquartered in Vaulx-en-Velin, France.